Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 2 2

Status

Terminated 2Recruiting 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

CNS 5Dermatologic 1

Conditions

Brain Neoplasms 3Xanthomatosis, Cerebrotendinous 1Recurrence 1Oligodendroglioma 1Melanoma 1Medulloblastoma 1Influenza, Human 1Glioma 1Diffuse Intrinsic Pontine Glioma 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Specimen Handling 124Capecitabine 124Temozolomide 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Diphtheria-Tetanus Vaccine × Clear all
NCT06254326 2026-05-27

ADAGiO

University of Florida

Phase 1 Recruiting
12 enrolled
CNS

Brain Neoplasms, Oligodendroglioma

NCT03334305 2026-04-23

ACTION

University of Florida

Phase 1 Terminated
18 enrolled 11 charts
CNS

Glioma

NCT06514898 2026-04-03

MATCHPOINT

University of Florida

Phase 1 Active not recruiting
12 enrolled
CNS

Medulloblastoma

NCT03396575 2025-10-29

BRAVO

University of Florida

Phase 1 Terminated
11 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Influenza, Human, Xanthomatosis, Cerebrotendinous

NCT05077137 2025-08-27

TdVax

Duke University

Phase 1 Recruiting
25 enrolled
Dermatologic

Melanoma

NCT02193347 2023-12-01

RESIST

Duke University

Phase 1 Completed
24 enrolled 8 charts
CNS

Brain Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡